Treatment approach for patients diagnosed with hepatocellular carcinoma in the national cancer center in Nicaragua

Abstract

surgical resection has a OS median of 21 months and a maximum survival of 32 months; patients treated with locoregional treatments had a maximum OS of 40 months with a median of 14 months; As for patients who received systemic treatment from the moment of diagnosis had a maximum survival of 22 months with a median of 10 months and those who did not received any treatment had a survival of 8 months. Conclusion: The majority of patients were diagnosed in intermediate and advanced stages, the best survival rates were achieved with surgical resection, followed by TACE. The OS median was 12 months and the EFS median was 9 months, mainly for early stages. A strategical plan for the early diagnosis of HCC is needed in order to obtain better survival rates in patients with HCC.